Advertisement

Immunologic Research

, Volume 64, Issue 1, pp 204–212 | Cite as

Positive association of genetic variations in the phospholipase C-like 1 gene with dermatomyositis in Chinese Han

  • Qian Wang
  • Si Chen
  • Yuan Li
  • Ping Li
  • Chanyuan Wu
  • Ziyan Wu
  • Qingjun Wu
  • Fei Sun
  • Jing Li
  • Wenjie Zheng
  • Chuiwen Deng
  • Fengchun Zhang
  • Yongzhe LiEmail author
Original Article

Abstract

Idiopathic inflammatory myopathies (IIMs) are autoimmune diseases with an underlying yet undefined genetic component. Recently, phospholipase C-like 1 (PLCL1) has been identified as a potential genetic susceptibility locus for dermatomyositis (DM) in patients of European ancestry. Here, association between PLCL1 polymorphisms and IIMs was investigated in Chinese Han. Genomic DNA was isolated from blood samples (2 mL) collected from Chinese Han (≥18 years) with polymyositis (PM, n = 286) or dermatomyositis (DM, n = 535) and ethnically matched controls (n = 968). Patients and controls were genotyped for five SNPs (rs938929, rs1518364, rs6738825, rs2117339, and rs7572733) previously associated with DM, with the Sequenom MassARRAY system. SNPs rs6738825 and rs7572733 were found to be associated with the development of DM in Chinese Han (P c = 0.015; P c = 0.025, respectively) as well as the risk A allele of rs938929 and T allele of rs1518364 (P c = 0.030; P c = 0.029). None of the five SNPs were associated with PM (all P c > 0.05). The frequency of the two haplotypes of these five SNPs was also significantly different between DM patients and healthy controls. In addition, conditional analysis with rs6738825 revealed that these SNPs were not independent factors contributing to DM. Finally, a novel association between rs6738825 and rs7572733 and DM with complicating interstitial lung disease was observed (ILD; P c = 0.040; P c = 0.030, respectively). A positive association between PLCL1 polymorphisms and DM patients and DM patients with ILD was observed, indicating that PLCL1 might be the susceptibility gene for DM patients in Chinese Han.

Keywords

Dermatomyositis Polymyositis Phospholipase C-like 1 gene Polymorphism Association 

Notes

Acknowledgments

We would like to give our sincere appreciation and thanks to all the patients with PM/DM, who made this study possible, to Chunwei Cao for the useful suggestion he offered, and to Yang Du for the expertise and technical assistance.

Funding

This work was supported by funding from the Research Special Fund for Public Welfare Industry of Health (201202004), and the National Natural Science Foundation of China Grants (81172857, 81373188), the Chinese National High Technology Research and Development Program, Ministry of Science and Technology Grants (2011AA02A113), the National Science Technology Pillar Program in the 12th Five-year Plan (2014BAI07B00), and the Capital Health Research and Development of Special (2014-1-4011).

Compliance with ethical standards

The study was approved by the Ethics Committee of the Peking Union Medical College Hospital.

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Supplementary material

12026_2015_8738_MOESM1_ESM.doc (526 kb)
Supplementary material 1 (DOC 526 kb)

References

  1. 1.
    Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med. 1991;325:1487–98.CrossRefPubMedGoogle Scholar
  2. 2.
    Dalakas MC, Sivakumar K. The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis. Curr Opin Neurol. 1996;9:235–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin N Am. 2002;28:723–41.CrossRefGoogle Scholar
  4. 4.
    Engel AG, Arahata K, Emslie-Smith A. Immune effector mechanisms in inflammatory myopathies. Res Publ Assoc Res Nerv Ment Dis. 1990;68:141–57.PubMedGoogle Scholar
  5. 5.
    Hilton-Jones D. Inflammatory muscle diseases. Curr Opin Neurol. 2001;14:591–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. III: immunoelectron microscopy aspects of cell-mediated muscle fiber injury. Ann Neurol. 1986;19:112–25.CrossRefPubMedGoogle Scholar
  7. 7.
    Chen IJ, Jan WY, Lin CW, Fan KW, Luo SF, Ho HH, et al. Interstitial lung disease in polymyositis and dermatomyositis. Clin Rheumatol. 2009;28:639–46.CrossRefPubMedGoogle Scholar
  8. 8.
    Ye S, Chen XX, Lu XY, Wu MF, Deng Y, Huang WQ, et al. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol. 2007;26:1647–54.CrossRefPubMedGoogle Scholar
  9. 9.
    Won HJ, Soon KD, Keun LC, Yoo B, Bum SJ, Kitaichi M, et al. Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis. Respir Med. 2007;101:1761–9.CrossRefGoogle Scholar
  10. 10.
    Hirakata M. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions. Nihon Rinsho Meneki Gakkai Kaishi. 2007;30:444–54.CrossRefPubMedGoogle Scholar
  11. 11.
    Chinoy H, Lamb JA, Ollier WE, Cooper RG. Recent advances in the immunogenetics of idiopathic inflammatory myopathy. Arthritis Res Ther. 2011;13:216.PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Gono T, Kawaguchi Y, Kuwana M, Sugiura T, Furuya T, Takagi K, et al. Brief report: association of HLA-DRB1*0101/*0405 with susceptibility to anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis in the Japanese population. Arthritis Rheumatol. 2012;64:3736–40.CrossRefGoogle Scholar
  13. 13.
    Chinoy H, Adimulam S, Marriage F, New P, Vincze M, Zilahi E, et al. Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann Rheum Dis. 2012;71:961–5.PubMedCentralCrossRefPubMedGoogle Scholar
  14. 14.
    Hassan AB, Nikitina-Zake L, Sanjeevi CB, Lundberg IE, Padyukov L. Association of the proinflammatory haplotype (MICA5.1/TNF2/TNFa2/DRB1*03) with polymyositis and dermatomyositis. Arthritis Rheumatol. 2004;50:1013–5.CrossRefGoogle Scholar
  15. 15.
    Pachman LM, Liotta-Davis MR, Hong DK, Kinsella TR, Mendez EP, Kinder JM, et al. TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. Arthritis Rheumatol. 2000;43:2368–77.CrossRefGoogle Scholar
  16. 16.
    Mamyrova G, O’Hanlon TP, Sillers L, Malley K, James-Newton L, Parks CG, et al. Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis. Arthritis Rheumatol. 2008;58:3941–50.CrossRefGoogle Scholar
  17. 17.
    Chinoy H, Salway F, John S, Fertig N, Tait BD, Oddis CV, et al. Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies. Rheumatol (Oxf). 2007;46:1411–6.CrossRefGoogle Scholar
  18. 18.
    Chinoy H, Salway F, John S, Fertig N, Tait BD, Oddis CV, et al. Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UK. Ann Rheum Dis. 2007;66:970–3.PubMedCentralCrossRefPubMedGoogle Scholar
  19. 19.
    Gono T, Kawaguchi Y, Sugiura T, Furuya T, Kawamoto M, Hanaoka M, et al. Interferon-induced helicase (IFIH1) polymorphism with systemic lupus erythematosus and dermatomyositis/polymyositis. Mod Rheumatol. 2010;20:466–70.CrossRefPubMedGoogle Scholar
  20. 20.
    Werth VP, Berlin JA, Callen JP, Mick R, Sullivan KE. Mannose binding lectin (MBL) polymorphisms associated with low MBL production in patients with dermatomyositis. J Invest Dermatol. 2002;119:1394–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Chinoy H, Li CK, Platt H, Fertig N, Varsani H, Gunawardena H, et al. Genetic association study of NF-kappaB genes in UK Caucasian adult and juvenile onset idiopathic inflammatory myopathy. Rheumatology (Oxford). 2012;51:794–9.CrossRefGoogle Scholar
  22. 22.
    O’Hanlon TP, Rider LG, Schiffenbauer A, Targoff IN, Malley K, Pandey JP, et al. Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies. Arthritis Rheumatol. 2008;58:3239–46.CrossRefGoogle Scholar
  23. 23.
    Chinoy H, Platt H, Lamb JA, Betteridge Z, Gunawardena H, Fertig N, et al. The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients. Arthritis Rheumatol. 2008;58:3247–54.CrossRefGoogle Scholar
  24. 24.
    Sugiura T, Kawaguchi Y, Goto K, Hayashi Y, Tsuburaya R, Furuya T, et al. Positive association between STAT4 polymorphisms and polymyositis/dermatomyositis in a Japanese population. Ann Rheum Dis. 2012;71:1646–50.CrossRefPubMedGoogle Scholar
  25. 25.
    Miller FW, Cooper RG, Vencovsky J, Rider LG, Danko K, Wedderburn LR, et al. Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. Arthritis Rheumatol. 2013;65:3239–47.CrossRefGoogle Scholar
  26. 26.
    Hinds DA, McMahon G, Kiefer AK, Do CB, Eriksson N, Evans DM, et al. A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci. Nat Genet. 2013;45:907–11.PubMedCentralCrossRefPubMedGoogle Scholar
  27. 27.
    Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet. 2010;42:1118–25.PubMedCentralCrossRefPubMedGoogle Scholar
  28. 28.
    Ramos PS, Criswell LA, Moser KL, Comeau ME, Williams AH, Pajewski NM, et al. A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap. PLoS Genet. 2011;7:e1002406.PubMedCentralCrossRefPubMedGoogle Scholar
  29. 29.
    Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344–7.CrossRefPubMedGoogle Scholar
  30. 30.
    Orens JB, Kazerooni EA, Martinez FJ, Curtis JL, Gross BH, Flint A, et al. The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy. A prospective study. Chest. 1995;108:109–15.PubMedGoogle Scholar
  31. 31.
    Preliminary criteria for the classification of systemic sclerosis. (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheumatol. 1980;23:581–90.CrossRefGoogle Scholar
  32. 32.
    Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheumatol. 1997;40:1725.CrossRefGoogle Scholar
  33. 33.
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheumatol. 1988;31:315–24.CrossRefGoogle Scholar
  34. 34.
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren’s syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.PubMedCentralCrossRefPubMedGoogle Scholar
  35. 35.
    Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease–an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52:148–59.CrossRefPubMedGoogle Scholar
  36. 36.
    Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol. 2002;46:626–36.CrossRefPubMedGoogle Scholar
  37. 37.
    Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet. 2006;38:209–13.CrossRefPubMedGoogle Scholar
  38. 38.
    Barrett JC. Haploview: Visualization and analysis of SNP genotype data. Cold Spring Harb Protoc. 2009;2009:p71.CrossRefGoogle Scholar
  39. 39.
    Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics. 2003;19:149–50.CrossRefPubMedGoogle Scholar
  40. 40.
    Newton-Cheh C, Hirschhorn JN. Genetic association studies of complex traits: Design and analysis issues. Mutat Res. 2005;573:54–69.CrossRefPubMedGoogle Scholar
  41. 41.
    Rider LG, Miller FW. Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies. JAMA. 2011;305:183–90.PubMedCentralCrossRefPubMedGoogle Scholar
  42. 42.
    Jani M, Massey J, Wedderburn LR, Vencovsky J, Danko K, Lundberg IE, et al. Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies. Ann Rheum Dis. 2014;73:1750–2.PubMedCentralCrossRefPubMedGoogle Scholar
  43. 43.
    Lin X, Varnai P, Csordas G, Balla A, Nagai T, Miyawaki A, et al. Control of calcium signal propagation to the mitochondria by inositol 1,4,5-trisphosphate-binding proteins. J Biol Chem. 2005;280:12820–32.CrossRefPubMedGoogle Scholar
  44. 44.
    Watanabe M, Maemura K, Kanbara K, Tamayama T, Hayasaki H. GABA and GABA receptors in the central nervous system and other organs. Int Rev Cytol. 2002;213:1–47.CrossRefPubMedGoogle Scholar
  45. 45.
    Kanematsu T, Fujii M, Mizokami A, Kittler JT, Nabekura J, Moss SJ, et al. Phospholipase C-related inactive protein is implicated in the constitutive internalization of GABAA receptors mediated by clathrin and AP2 adaptor complex. J Neurochem. 2007;101:898–905.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Qian Wang
    • 1
  • Si Chen
    • 1
  • Yuan Li
    • 1
  • Ping Li
    • 1
  • Chanyuan Wu
    • 1
  • Ziyan Wu
    • 1
  • Qingjun Wu
    • 1
  • Fei Sun
    • 1
  • Jing Li
    • 1
  • Wenjie Zheng
    • 1
  • Chuiwen Deng
    • 1
  • Fengchun Zhang
    • 1
  • Yongzhe Li
    • 1
    Email author
  1. 1.Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Key Laboratory of Rheumatology and Clinical ImmunologyMinistry of EducationBeijingChina

Personalised recommendations